The recommended dosage is a single subcutaneous injection administered once per chemotherapy cycle. Neulasta® is supplied as a preservative-free solution containing 6 mg of pegfilgrastim (10 mg/mL) in a prefilled single-dose syringe with a 27-gauge, 1/2-inch needle and an UltraSafe® Needle Guard. It should be administered at least 24 hours after myelosuppressive chemotherapy, but no sooner than 14 days prior to the next cycle.
More.
I cant really gove you an answer,but what I can give you is a way to a solution, that is you have to find the anglde that you relate to or peaks your interest. A good paper is one that people get drawn into because it reaches them ln some way.As for me WW11 to me, I think of the holocaust and the effect it had on the survivors, their families and those who stood by and did nothing until it was too late.